An Open-label Bosutinib Treatment Extension Study for Subjects with Chronic Myeloid Leukemia (CML) who have Previously Participated in Bostutinib Studies B1871006 or B1871008 - Regional Cancer Care Associates LLC

Clinical Trials

An Open-label Bosutinib Treatment Extension Study for Subjects with Chronic Myeloid Leukemia (CML) who have Previously Participated in Bostutinib Studies B1871006 or B1871008

Type of Cancer
Leukemia
Locations
Bethesda
Sponsor
Protocol Number
B1871040-1134
Cancer Diagnosis
To Learn More Call
201-510-0910